FRUSCIO, ROBERT
 Distribuzione geografica
Continente #
NA - Nord America 21.787
AS - Asia 14.405
EU - Europa 11.041
SA - Sud America 2.219
AF - Africa 253
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 25
Totale 49.786
Nazione #
US - Stati Uniti d'America 21.202
SG - Singapore 5.051
CN - Cina 3.372
IT - Italia 2.455
HK - Hong Kong 2.347
RU - Federazione Russa 1.993
VN - Vietnam 1.830
BR - Brasile 1.696
DE - Germania 1.237
IE - Irlanda 1.171
SE - Svezia 1.052
UA - Ucraina 685
GB - Regno Unito 642
FR - Francia 395
CA - Canada 375
FI - Finlandia 319
ID - Indonesia 316
IN - India 293
KR - Corea 257
TR - Turchia 221
AT - Austria 202
NL - Olanda 190
AR - Argentina 177
JP - Giappone 165
MX - Messico 152
ES - Italia 149
BD - Bangladesh 120
ZA - Sudafrica 98
CO - Colombia 96
PL - Polonia 94
DK - Danimarca 90
IQ - Iraq 80
EC - Ecuador 73
BE - Belgio 65
AU - Australia 46
CH - Svizzera 44
EG - Egitto 43
VE - Venezuela 42
CL - Cile 41
SA - Arabia Saudita 40
PE - Perù 37
GR - Grecia 36
MA - Marocco 36
PT - Portogallo 34
IR - Iran 33
CZ - Repubblica Ceca 30
PK - Pakistan 29
SK - Slovacchia (Repubblica Slovacca) 29
AE - Emirati Arabi Uniti 28
TH - Thailandia 28
PH - Filippine 27
PY - Paraguay 27
RO - Romania 24
LT - Lituania 23
BG - Bulgaria 19
IL - Israele 19
UY - Uruguay 19
UZ - Uzbekistan 19
EU - Europa 15
KE - Kenya 14
TN - Tunisia 14
AL - Albania 12
LV - Lettonia 12
MY - Malesia 12
TW - Taiwan 12
DZ - Algeria 11
JM - Giamaica 10
JO - Giordania 10
OM - Oman 10
HN - Honduras 9
KW - Kuwait 9
LK - Sri Lanka 9
A2 - ???statistics.table.value.countryCode.A2??? 8
NP - Nepal 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
NG - Nigeria 7
PS - Palestinian Territory 7
RS - Serbia 7
SN - Senegal 7
AZ - Azerbaigian 6
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
KH - Cambogia 6
NZ - Nuova Zelanda 6
PA - Panama 6
BY - Bielorussia 5
CR - Costa Rica 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
CI - Costa d'Avorio 4
GY - Guiana 4
HR - Croazia 4
NI - Nicaragua 4
QA - Qatar 4
AM - Armenia 3
BH - Bahrain 3
Totale 49.727
Città #
Ann Arbor 3.294
Singapore 2.875
Hong Kong 2.309
Ashburn 1.968
Woodbridge 1.570
Fairfield 1.493
Dublin 1.113
Houston 1.092
Chandler 948
Wilmington 825
Jacksonville 692
Seattle 648
Frankfurt am Main 617
Hefei 602
New York 596
Ho Chi Minh City 568
Milan 568
Santa Clara 521
Cambridge 520
Dearborn 488
Dallas 471
Hanoi 428
Princeton 426
Beijing 403
Los Angeles 401
Jakarta 263
Seoul 239
Hangzhou 222
Moscow 211
Nanjing 210
The Dalles 197
Lawrence 191
Shanghai 188
Chicago 187
Altamura 170
Buffalo 167
Boardman 163
São Paulo 143
Vienna 141
Lachine 112
Rome 109
Nuremberg 107
San Diego 103
Helsinki 102
Tokyo 100
Guangzhou 97
London 97
Munich 89
Lissone 85
Nanchang 79
Council Bluffs 72
Ottawa 64
Brooklyn 63
Toronto 63
Andover 62
Lappeenranta 59
Rio de Janeiro 58
Shenyang 57
Warsaw 57
Dong Ket 56
Johannesburg 55
Montreal 55
Da Nang 52
Fremont 52
Istanbul 52
Chennai 49
Changsha 48
Denver 48
Haiphong 48
Kent 48
Salt Lake City 48
Atlanta 47
Jinan 45
Hebei 44
Brussels 41
Poplar 41
Columbus 39
Mexico City 39
Tianjin 38
Amsterdam 37
Kunming 37
Phoenix 37
Ankara 36
Belo Horizonte 36
San Francisco 36
Turku 36
Ninh Bình 35
Stockholm 35
Biên Hòa 34
Falls Church 34
Ha Long 34
Boston 33
Brasília 33
Florence 33
San Jose 33
Norwalk 32
Orem 32
Porto Alegre 32
Quận Bình Thạnh 32
Zhengzhou 32
Totale 31.427
Nome #
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 983
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 865
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 503
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 474
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 469
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations 437
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 415
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 388
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 386
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 373
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 373
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 350
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 345
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 342
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 317
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 314
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 312
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 309
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 308
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 300
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 293
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 289
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 288
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 284
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 279
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 279
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 276
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 275
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 273
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 270
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 269
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 263
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 262
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 262
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 255
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 254
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 252
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 251
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 250
Delaying surgery for patients with a previous SARS-CoV-2 infection 249
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 247
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 245
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 244
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 238
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 234
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 232
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 230
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 229
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 228
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 226
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 225
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 224
Synchronous early-stage endometrial and ovarian cancer 223
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 222
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 222
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 222
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 221
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 220
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 219
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 219
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 218
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 215
PRL-3 phosphatase is implicated in ovarian cancer growth 213
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 213
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 211
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 208
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 207
Managing Ovarian tumors during pregnancy 207
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 206
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 205
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 205
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 203
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 203
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 201
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 198
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study 196
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 196
Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa 196
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 195
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 193
Borderline ovarian cancer 192
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 191
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 190
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 190
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 190
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 190
The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer 188
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 187
Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumour Analysis) 4 cohort 187
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 186
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 186
The role of transvaginal ultrasound in the workup of invasive molar disease 186
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 185
Prognosis of patients with cervical cancer diagnosed during pregnancy 184
Systematic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgery and chemotherapy: a retrospective study 183
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 181
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 180
Melanoma during pregnancy: A report of 60 pregnancies complicated by melanoma 180
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 179
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery 179
Totale 26.309
Categoria #
all - tutte 180.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.654 0 0 0 0 0 355 427 496 374 424 226 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/202511.485 583 1.228 523 532 901 610 604 537 1.227 1.683 1.027 2.030
2025/202613.731 3.093 2.037 1.923 2.581 2.816 1.281 0 0 0 0 0 0
Totale 51.064